Appili Therapeutics Inc.

TSX:APLI Voorraadrapport

Marktkapitalisatie: CA$4.2m

Appili Therapeutics Beheer

Beheer criteriumcontroles 2/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Don Cilla

Algemeen directeur

CA$622.6k

Totale compensatie

Percentage CEO-salaris80.4%
Dienstverband CEO2yrs
Eigendom CEO0.06%
Management gemiddelde ambtstermijn2yrs
Gemiddelde ambtstermijn bestuur5.5yrs

Recente managementupdates

Recent updates

Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Mar 24
Market Sentiment Around Loss-Making Appili Therapeutics Inc. (TSE:APLI)

Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Dec 09
Appili Therapeutics Inc.'s (TSE:APLI) Shift From Loss To Profit

Analyse CEO-vergoeding

Hoe is Don Cilla's beloning veranderd ten opzichte van Appili Therapeutics's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-CA$4m

Mar 31 2024CA$623kCA$501k

-CA$4m

Dec 31 2023n/an/a

-CA$5m

Sep 30 2023n/an/a

-CA$8m

Jun 30 2023n/an/a

-CA$8m

Mar 31 2023CA$608kCA$433k

-CA$9m

Dec 31 2022n/an/a

-CA$10m

Sep 30 2022n/an/a

-CA$11m

Jun 30 2022n/an/a

-CA$20m

Mar 31 2022CA$747kCA$477k

-CA$25m

Dec 31 2021n/an/a

-CA$27m

Sep 30 2021n/an/a

-CA$28m

Jun 30 2021n/an/a

-CA$19m

Mar 31 2021CA$627kCA$170k

-CA$14m

Compensatie versus markt: Don's total compensation ($USD446.10K) is above average for companies of similar size in the Canadian market ($USD171.96K).

Compensatie versus inkomsten: Don's compensation has increased whilst the company is unprofitable.

CEO

Don Cilla

2yrs

Tenure

CA$622,595

Compensatie

Dr. Donald D. Cilla, also known as Don, Jr., PharmD, MBA, serves as Chief Executive Officer, President and Director at Appili Therapeutics Inc. since November 13, 2022 and served as its Chief Development O...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Donald Cilla
CEO, President & Director2yrsCA$622.60k0.062%
CA$ 2.6k
Kenneth Howling
Chief Financial Officer3yrsCA$499.44kgeen gegevens
Gary Nabors
Chief Development Officer1.6yrsCA$548.01kgeen gegevens
Carl Gelhaus
Director of Non-Clinical Researchno dataCA$301.26kgeen gegevens
Arthur Baran
Director of New Product Developmentno dataCA$313.76kgeen gegevens

2.0yrs

Gemiddelde duur

Ervaren management: APLI's management team is considered experienced (2 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Donald Cilla
CEO, President & Director2yrsCA$622.60k0.062%
CA$ 2.6k
Lidija Marusic
Board Observer5.5yrsgeen gegevensgeen gegevens
Prakash Gowd
Independent Directorless than a yearCA$30.23kgeen gegevens
Lynn Silver
Member of Advisory Boardno datageen gegevensgeen gegevens
Dean Shinabarger
Member of Advisory Boardno datageen gegevensgeen gegevens
Brian Bloom
Independent Director9.5yrsCA$63.10kgeen gegevens
Juergen Froehlich
Independent Director4.8yrsCA$84.10kgeen gegevens
Armand Balboni
Chairman of the Board5.8yrsCA$39.00kgeen gegevens
Theresa Matkovits
Lead Independent Director6.1yrsCA$131.60kgeen gegevens
Sridhar Narayan
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens

5.5yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: APLI's board of directors are considered experienced (5.5 years average tenure).